CTIS2022-502077-42-00招募中1 期
A Phase 2/3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP 363856 in the Treatment of Adults with Generalized Anxiety Disorder - SEP361-226
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 434
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Male or female subject between 18 to 65 years of age., Subject meets DSM-5 criteria for a diagnosis of Generalized Anxiety Disorder, Subject must be willing and able to comply with the study procedures and visit schedule and must be able to understand and follow verbal and written instructions.
排除标准
- •Subject has a current DSM-5 diagnosis or presence of symptoms consistent with a major psychiatric disorder, other than Generalized Anxiety Disorder, that is the primary focus of treatment, Subjects who report an inadequate response to more than 3 antidepressant treatments, Subject is at significant risk of harming self or others based on Investigator’s judgement., Subject has any clinically significant unstable medical condition or any clinically significant chronic disease that in the opinion of the Investigator, would limit the subject’s ability to complete and/or participate in the study., Female subject who is pregnant, lactating, or plans to get pregnant during the study
研究者
相似试验
进行中（未招募）
1 期
A study of anifrolumab in children and adolescents (5 to < 18 years old) with moderate to severe lupus to find the appropriate anifrolumab dose for those participants and to confirm anifrolumab is safe and works in this populatioModerate to Severe Active Systemic Lupus ErythematosusMedDRA version: 21.1Level: PTClassification code: 10042945Term: Systemic lupus erythematosus Class: 100000004859CTIS2022-502289-25-00AstraZeneca AB100
招募中
3 期
To Study the Efficacy, Safety and Immunogenicity of Aflibercept in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)CTRI/2023/09/057655Zydus Lifesciences Limited
已完成
3 期
Phase III clinical study to compare safety and efficacy of 2 Dosage of Telmisartan and Azelnidipine when compared to Telmisartan and Almlodipine in Patients with Stage II HypertensioCTRI/2019/12/022543Synokem Pharmaceuticals Ltd210
已完成
3 期
A clinical trial to study the effects of combination of Rosuvastatin plus Teneligliptin Tablets in diabetic patients with high lipid levels.CTRI/2019/12/022548Synokem Pharmaceuticals Ltd252
进行中（未招募）
1 期
A study to compare SYN008 and Xolair for the treatment of chronic urticaria not well controlled by antihistaminesChronic spontaneous urticaria (Allergic asthma, Chronic rhinosinusitis with nasal polyps)MedDRA version: 20.0Level: PTClassification code 10072757Term: Chronic spontaneous urticariaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 21.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.1Level: PTClassification code 10080060Term: Chronic rhinosinusitis with nasal polypsSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2021-000149-42-HUSynermore Biologics Co., Ltd480